UPMC Hillman Cancer Center ( Site 6004) — Pittsburgh, Pennsylvania

UPMC Hillman Cancer Center ( Site 6004) is a clinical research site located in Pittsburgh, Pennsylvania, United States 15232.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

UPMC Hillman Cancer Center ( Site 6004) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Thrombocythemia, Essential, Primary Myelofibrosis, Myelofibrosis.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UPMC Hillman Cancer Center ( Site 6004)?

UPMC Hillman Cancer Center ( Site 6004) has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UPMC Hillman Cancer Center ( Site 6004) conducted?

UPMC Hillman Cancer Center ( Site 6004) has 1 clinical trials on record, with 1 currently active. Their work covers Thrombocythemia, Essential, Primary Myelofibrosis, Myelofibrosis.

Is UPMC Hillman Cancer Center ( Site 6004) accredited by Crixeo Health?

UPMC Hillman Cancer Center ( Site 6004) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UPMC Hillman Cancer Center ( Site 6004)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.